// App-Quantinova.ai

1250 : A novel in vivo PBMC humanized mouse platform for long-term analysis of efficacy and toxicity of T cell-based immunotherapy drugs

Researchers

Presenter

  • Guoxiang Yang

Principal Investigators

  • Hongyuan Yang

  • Li-Chin Yao

  • Leonard Shultz

  • Danying Cai

  • James Keck

  • Mingshan Cheng

Medical Centers

  • The Jackson Laboratory, Sacramento, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

  • Breast cancer

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 19

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved